Merck & Co and Bayer agree their own asset-swapping megadeal

Bayer has won the auction for Merck & Co's consumer care business with a cash offer of $14.2bn. The companies also plan to collaborate in the field of sGC (soluble guanylate cyclase) modulators, for which Merck will make an upfront payment to Bayer of $1bn.

More from Cardiovascular

More from Therapy Areas